These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 38061484)

  • 1. The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways.
    Ren L
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110910. PubMed ID: 38061484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
    Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
    Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions.
    Lewis V; Rurak G; Salmaso N; Aguilar-Valles A
    Trends Neurosci; 2024 Mar; 47(3):195-208. PubMed ID: 38220554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.
    Abdallah CG; Adams TG; Kelmendi B; Esterlis I; Sanacora G; Krystal JH
    Depress Anxiety; 2016 Aug; 33(8):689-97. PubMed ID: 27062302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.
    Aleksandrova LR; Phillips AG; Wang YT
    J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect.
    Bottemanne H; Berkovitch L; Gauld C; Balcerac A; Schmidt L; Mouchabac S; Fossati P
    Neurosci Biobehav Rev; 2023 Nov; 154():105410. PubMed ID: 37793581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders.
    Lewis V; Rodrigue B; Arsenault E; Zhang M; Taghavi-Abkuh FF; Silva WCC; Myers M; Matta-Camacho E; Aguilar-Valles A
    J Neurochem; 2023 Jul; 166(1):10-23. PubMed ID: 35680556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.
    Chen T; Cheng L; Ma J; Yuan J; Pi C; Xiong L; Chen J; Liu H; Tang J; Zhong Y; Zhang X; Liu Z; Zuo Y; Shen H; Wei Y; Zhao L
    Pharmacol Res; 2023 Aug; 194():106837. PubMed ID: 37379962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
    Suzuki K; Monteggia LM
    Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms.
    Krystal JH; Kavalali ET; Monteggia LM
    Neuropsychopharmacology; 2024 Jan; 49(1):41-50. PubMed ID: 37488280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions.
    Onisiforou A; Georgiou P; Zanos P
    Pharmacol Biochem Behav; 2023 Feb; 223():173531. PubMed ID: 36841543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics.
    Kojic M; Saelens J; Kadriu B; Zarate CA; Kraus C
    Curr Top Behav Neurosci; 2022; 56():141-167. PubMed ID: 35312993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
    Hashimoto K
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine: The final frontier or another depressing end?
    Sial OK; Parise EM; Parise LF; Gnecco T; Bolaños-Guzmán CA
    Behav Brain Res; 2020 Apr; 383():112508. PubMed ID: 32017978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants.
    Kato T
    Neuropharmacology; 2023 Feb; 223():109325. PubMed ID: 36334763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine: Leading us into the future for development of antidepressants.
    Carreno FR; Lodge DJ; Frazer A
    Behav Brain Res; 2020 Apr; 383():112532. PubMed ID: 32023492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.